Skip to main content

Didactics

Academy of Teaching ScholarsThe fellowship program involves a series of didactic classes designed to provide basic skills in clinical design, pharmacokinetics and pharmacogenetics, biomarker assessment and development, as well as ethical issues in clinical research. Didactic courses take place within a rich academic research environment that involves the study of therapeutics in humans of all ages and ethnicities.

Friday Didactics Schedules

  • 2024

    Schedule is subject to change.

     

    January 19, 2024

    Statistical Analysis 1: Continuous Data
    Paul Berg, MS & Forrest Williamson, PhD, MS

    January 26, 2024

    Statistical Analysis 2: Categorical Data
    Paul Berg, MS and Forrest Williamson, PhD, MS

    February 2, 2024

    Statistical Tests and Model Building
    Paul Berg, MS and Forrest Williamson, PhD, MS

    February 9, 2024

    Human Studies 1 (Design)
    Paul Berg, MS and Forrest Williamson, PhD, MS

    February 16, 2024

    Human Studies 2 (Analysis/Interpretations)
    Paul Berg, MS and Forrest Williamson, PhD, MS

    February 23, 2024

    Statistical Methods for Clinical Pharmacology
    Paul Berg, MS and Forrest Williamson, PhD, MS

  • 2023

    February 3, 2023

    Introduction/Phase 1
    Eric Benson, MD and Tom Callaghan, MD, PhD


    February 10, 2023

    Toxicology
    Thomas Jones, PhD


    February 17, 2023

    Application of Artificial Intelligence and Machine Learning for Precision Medicine
    Workshop by Indiana CTSI WGHI Winter Retreat


    February 24, 2023

    NO DIDACTIC - SYMPOSIUM

     

    March 3, 2023

    Biomarker Development
    Tom Callaghan, MD, PhD


    March 10, 2023

    Precision Oncology Trials
    Tom Callaghan, MD, PhD

     

    March 17, 2023

    NO DIDACTIC - SPRING BREAK

     

    March 24, 2023

    Preclinical Pharmacology
    Andrew Dahlem, DVM (hc), PhD

     

    March 31, 2023

    Late Phase Trial Development
    William Macias, MD, PhD

     

    April 7, 2023

    Role of Modeling
    Robert Stratford, PhD

     

    April 14, 2023

    Ethical Considerations and Rare Diseases
    Tim Franson, MD

     

    April 21, 2023
     
    Special Populations: Gender, Disease, Age, and Other Covariates
    Richard Bergstrom, PhD
     
    April 28, 2023
     
    Special Populations:Hepatic/Renal Impaired States
    Michael Eadon, MD

     

    August 25, 2023

    Drug Measurement 1 -- Small Molecules
    Lais Da Silva, PhD

     

    September 1, 2023

    Drug Measurement 2 -- Macromolecular Drugs
    Ronald Bowsher, PhD

     

    September 8, 2023

    CH 1, 2 Therapeutic Relevance; Fundamental Concepts and Terminology; Appendix A Assessment of AUC
    Richard Bergstrom, PhD and Brian Overholser, PharmD

     

    September 15, 2023

    CH 3 Kinetics Following and Intravenous Bolus Dose: Appendix H Mean Residence Time
    Kevin Sowinski, PharmD

     

    September 22, 2023

    CH 4, 19 Membranes and Distribution; Distribution Kinetics Appendix B Ionization an pH Partition Hypothesis; Appendix C Distribution of Drugs Extensively Bound to Plasma Proteins
    Sara Quinney, PharmD, PhD

     

    September 29, 2023

    CH 5 Elimination; Appendix D Plasma-to-Blood Concentration Ratio; Appendix E Well-Stirred Model of Hepatic Clearance
    Brian Overholser, PharmD

     

    October 6, 2023

    CH 6, 7 Kinetics Following an Extravascular Dose; Absorption; Appendix F Absorption Kinetics; Appendix G Wagner-Nelson Method
    Kevin Sowinski, PharmD

     

    October 13, 2023

    CH 10 Constant-Rate Input
    Lais Da Silva, PhD

     

    October 20, 2023

    CH 8, 9 Response Following a Single Dose; Therapeutic Window
    Brian Overholser, PharmD

     

    October 27, 2023

    CH 11, 18 Multiple Dose Regimens; Initiating and Managing Therapy
    Richard Bergstrom, PhD

     

    November 3, 2023

    CH 17, 20 Metabolite and Drug Response; Drug Interaction
    Lais Da Silva, PhD

     

    November 10, 2023

    CH 12, 13 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PharmD, PhD

     

    November 17, 2023

    CH 14, 15 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PharmD, PhD

     

    November 24, 2023

    NO CLASS - THANKSGIVING BREAK



    December 1, 2023

    CH 16, Nonlinearities
    Sara Quinney, PharmD, PhD

     

    December 8, 2023

    CH 21, 22 Protein Drugs; Predictions of Human PK from Preclinical
    Richard Bergstrom, PhD

     

    December 15, 2023

    TAKE HOME FINAL EXAMINATION

  • 2022

    January 21, 2022
    Univariate Continuous Statistical Data Analysis
    Forrest Williamson, PhD

    January 28, 2022
    Univariate Categorical Statistical Data Analysis
    Forrest Williamson, PhD

    February 4, 2022
    Statistical Tests and Model Building
    Forrest Williamson, PhD
    Paul H Berg, MS

    February 11, 2022
    Human Studies 1 (Design)
    Paul H Berg, MS

    February 25, 2022
    Human Studies 2 (Analysis/Interpretations)
    Forrest Williamson, PhD
    Paul H Berg, MS

    March 4, 2022
    Statistical Methods Useful in Clinical Pharmacology
    Paul H Berg, MS

    August 12, 2022
    Pharmacogenetics: General Concepts
    Todd Skaar, PhD

    August 19, 2022
    Clinical Relevance of CYP2Cs Genetic Polymorphism I
    Zeruesenay Desta, PhD

    August 23, 2022
    Genotyping and Sequencing I (SPECIAL DAY - HELD ON TUESDAY IN LIEU OF SEMINAR)
    Todd Skaar, PhD

    August 26, 2022
    Genotyping and Sequencing II
    Todd Skaar, PhD

    September 2, 2022
    Clinical Relevance of CYP2Cs Genetic Polymorphism II
    Zeruesenay Desta, PhD

    September 9, 2022
    Pharmacogenetics of Phase II Metabolism: Glucuronidation
    Zeruesenay Desta, PhD

     

    September 16, 2022
    Pharmacogenetics of Phase II Metabolism: N-acetylation and Thiopurine Methyltransferase
    Zeruesenay Desta, PhD

    September 23, 2022
    Pharmacogenetics of CYP2D6
    Todd Skaar, PhD

    September 30, 2022
    Pharmacogenomics of CYP3A
    Todd Skaar, PhD

    October 7, 2022
    GWAS, Polygenic Models, and Secondary Big Data Analysis
    Nick Powell, PharmD

     

    October 14, 2022
    Phenoconversions 
    Tom Callaghan, MD, PhD

    October 21, 2022
    Clinical Implementation of Pharmacogenomic Testing
    Emma Tillman, Pharm D, PhD

     

    October 28, 2022
    Clinical Pharmacogenomics Testing
    Victoria Pratt, PhD, FACMG

     

    November 4, 2022
    Opioid Pharmacodynamics
    Tom Callaghan, MD, PhD

    November 11, 2022
    QT Prolongation
    Brian Overholser, PharmD, FDCP

     

    November 18, 2022
    Pharmacogenomics of Drug Transporters
    Michael Eadon, MD

    November 25, 2022
    No Didactics - Day After Thanksgiving Holiday

     

    December 2, 2022
    Pharmacogenomics of Hypertension Therapies
    Michael Eadon, MD

    December 9, 2022
    PGx Extraction
    Tyler Shugg, PharmD, PhD

     

    December 16, 2022
    Cancer Somatic Genomics
    Patrick Kiel, PharmD


  • 2021

    April 16, 2021
    Special Populations - Pregnancy
    Sara K. Quinney, PhD

    April 23, 2021
    Special Populations - Geriatric
    J. Thomas Callaghan, MD, PhD

    April 30, 2021
    Special Populations - Hepatic / Renal
    Michael T. Eadon, MD

    August 17, 2021
    Drug Measurement 1 - small molecule
    Andi Masters, MS

    September 3, 2021
    Drug Measurement 2 - macromolecular drugs
    Ronald Bowsher, PhD

    September 10, 2021
    Ch 1, 2 Therapeutic Relevance; Fundamental Concepts and Terminology;
    Appendix A Assessment of AUC

    Rich Bergstrom, PhD/Brian Overholser, PharmD

    September 17, 2021
    Ch 3 Kinetics Following and Intravenous Bolus Dose
    Appendix H Mean Residence Time
    Kevin Sowinski, PharmD

    September 24, 2021
    Ch 4, 19 Membranes and Distribution; Distribution Kinetics
    Appendix B Ionizabion an pH Partition Hypothesis; Appendix C
    Distribution of Drugs Extensively Bound to Plasma Proteins

    Sara Quinney, PhD

    October 1, 2021
    CH 5 Elimination; Appendix D Plasma-to-Blood Concentration Ratio;
    Appendix E Well-Stirred Model of Hepatic Clearance

    Brian Overholser, PharmD

    October 8, 2021
    CH 6, 7 Kinetics Following an Extravascular Dose; Absorption;
    Appendix F Absorption Kinetics; Appendix G Wagner-Nelson

    Kevin Sowinski, PharmD

    October 15, 2021
    CH 10 Constant-Rate Input
    Robert Stratford, PhD

    October 22, 2021
    CH 8, 9 Response Following a Single Dose; Therapeutic Window
    Brian Overholser, PharmD

    October 29, 2021
    CH 11, 18 Multiple Dose Regimens; Initiating and Managing
    Rich Bergstrom, PhD

    November 5, 2021
    CH 17, 20 Metabolite and Drug Response; Drug Interaction
    Robert Stratford, PhD

    November 12, 2021
    CH 12, 13 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PhD

    November 19, 2021
    CH 14, 15 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PhD

    November 26, 2021
    NO CLASS - THANKSGIVING BREAK

    December 3, 2021
    CH 16, Nonlinearities
    Sara Quinney, PhD

    December 10, 2021
    CH 21, 22 Protein Drugs; Predictions of Human PK from
    Rich Bergstrom,PhD

    December 17, 2021
    TAKE HOME FINAL EXAM

  • 2020

    January 10, 2020
    Statistical Analysis 1: Continuous Data
    Forrest Williamson, PhD

    January 17, 2020
    Statistacal Analysis 2 Categorical Data
    Forrest Williamson, PhD

    January 24, 2020
    Statistical Tests and Model Building
    Fanni Natanegara, PhD

    January 30, 2020
    Human Studies 1 (Design)
    Paul H. Berg, MS

    February 7, 2020
    Human Studies 2 (Analysis/Interpretations)
    Fanni Natanegara, PhD

    February 14, 2020
    Statistical Methods for Clinical Pharmacology
    Paul H. Berg, MS

    August 14, 2020
    Pharmacogenetics: General Concepts
    Todd Skaar, PhD

    August 21, 2020
    Clinical Relevance of CYP2C9 and CYP2C19 Genetic Polymorphism
    Zeruesenay Desta, PhD

    August 28, 2020
    Genotyping and Sequencing I
    Todd Skaar, PhD

    September 4, 2020
    Clinical Relevance of CYP2Cs Genetic Polymorphism
    Zeruesenay Desta, PhD

    September 11, 2020
    Genotyping and Sequencing II
    Todd Skaar, PhD

    September 18, 2020
    Pharmacogenetics of Phase II Metabolism: Glucuronidation
    Zeruesenay Desta, PhD

    September 25, 2020
    Pharmacogenetics of Phase II Metabolism: N-acetylation and Thiopurine Methyltransferase
    Zeruesenay Desta, PhD

    October 2, 2020
    Pharmacogenetics of CYP2D6
    Todd Skaar, PhD

    October 9, 2020
    Pharmacogenomics of CYP3A
    Todd Skaar, PhD

    October 16, 2020
    Phenoconversions
    Tom Callaghan, MD, PhD

    October 23, 2020
    No Didactics

    October 30, 2020
    No Didactics

    November 6, 2020
    Opioid Pharmacodynamics
    Tom Callaghan, MD, PhD

    November 13, 2020
    QT Prolongation
    Brian Overholser, PharmD, FDCP

    November 20, 2020
    Pharmacogenomics of Drug Transporters
    Michael Eadon, MD

    December 4, 2020
    Pharmacogenomics of Hypertension Therapies
    Michael Eadon, MD

    December 11, 2020
    Clinical Pharmacogenomics Testing
    Victoria Pratt, PhD, FACMG